CBDG (THC Farmaceuticals) Other Long-Term Liabilities: $0.03 Mil (As of Jun. 2018)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is THC Farmaceuticals Other Long-Term Liabilities?

THC Farmaceuticals CBDG Other Long-Term Liabilities is $0.03 Mil as of Jun. 2018.

THC Farmaceuticals's other long-term liabilities for the quarter that ended in Jun. 2018 was $0.03 Mil.

THC Farmaceuticals's quarterly other long-term liabilities increased from Jun. 2017 ($0.00 Mil) to Mar. 2018 ($0.03 Mil) but then stayed the same from Mar. 2018 ($0.03 Mil) to Jun. 2018 ($0.03 Mil).

THC Farmaceuticals's annual other long-term liabilities increased from Sep. 2011 ($0.02 Mil) to Sep. 2012 ($0.04 Mil) but then declined from Sep. 2012 ($0.04 Mil) to Sep. 2013 ($0.01 Mil).

THC Farmaceuticals Other Long-Term Liabilities Related Terms

THC Farmaceuticals Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for THC Farmaceuticals's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

THC Farmaceuticals Other Long-Term Liabilities Chart

THC Farmaceuticals Annual Data
Trend Sep10 Sep11 Sep12 Sep13
Other Long-Term Liabilities
0.04 0.02 0.04 0.01

THC Farmaceuticals Quarterly Data
Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Mar17 Jun17 Mar18 Jun18
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.03 0.03

THC Farmaceuticals Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of $0.03 Mil mean?
THC Farmaceuticals (CBDG) has a Other Long-Term Liabilities of $0.03 Mil as of Jun. 2018. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on THC Farmaceuticals and its competitors.
Is THC Farmaceuticals' Other Long-Term Liabilities too high?
THC Farmaceuticals' current Other Long-Term Liabilities is $0.03 Mil.
How does THC Farmaceuticals' Other Long-Term Liabilities compare to BOXS?
THC Farmaceuticals' Other Long-Term Liabilities of $0.03 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Biotechnology company?
A good Other Long-Term Liabilities depends on the Biotechnology industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on THC Farmaceuticals and its competitors. THC Farmaceuticals's current Other Long-Term Liabilities is $0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is THC Farmaceuticals stock overvalued right now?
THC Farmaceuticals (CBDG) has a current Other Long-Term Liabilities of $0.03 Mil. The current Other Long-Term Liabilities is $0.03 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For THC Farmaceuticals (CBDG), the current Other Long-Term Liabilities is $0.03 Mil as of Jun. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

THC Farmaceuticals Business Description

Address 2789 Rio Vista Drive, Suite 3, Saint George, UT, USA, 84790
THC Farmaceuticals Inc is a clinical-stage biotechnology company specializing in the discovery, development, and commercialization of novel cannabinoid-based products in dental, ophthalmology, and other medical disciplines. It offers the combination of proprietary developments with the expertise of clinicians and scientists to unlock the therapeutic properties of cannabis and its bioactive compounds.